orantinib has been researched along with a 419259 in 1 studies
| Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (a 419259) | Trials (a 419259) | Recent Studies (post-2010) (a 419259) |
|---|---|---|---|---|---|
| 8 | 0 | 7 | 19 | 0 | 15 |
| Protein | Taxonomy | orantinib (IC50) | a 419259 (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.2228 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.5224 | |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.1531 | |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | 0.0004 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.0004 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.3464 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.6462 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.024 | |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | 2.1555 | |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | 0.208 | |
| Angiopoietin-1 receptor | Homo sapiens (human) | 1.0121 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
1 other study(ies) available for orantinib and a 419259
| Article | Year |
|---|---|
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |